Sleep Medicine
From the Journals
Sleep disorders and cancer: It’s complicated
From the Journals
CBT prevents depression in up to 50% of patients with insomnia
The study is unique in that the treatment “is not just reducing depression, it’s preventing depression,” said Dr. Michael R. Irwin, lead author....
From the Journals
Swell in off-label antipsychotic prescribing ‘not harmless’
Clinicians should be made aware that low-dose treatment with these drugs for insomnia and anxiety “might come at a cost of shortening patients’...
From the Journals
Social media use associated with depression in adults
New data on adults reflects the link between social media and depression seen in youths.
From the Journals
Ferric carboxymaltose calms restless legs
Nearly two-thirds of patients with restless legs syndrome remained off RLS medications at 1 year after treatment.
Feature
What to do about pandemic PTSD
More than three-quarters of the health care workers reported symptoms that fell within the clinical range for depression (76%) and anxiety (78...
From the Journals
Do adolescents develop CNS autoimmunity after COVID-19?
The researchers examined three pediatric patients who were infected with SARS-CoV-2 and, over a period of 5 months in 2020, were admitted to the...
News
Step right up, folks, for a public dissection
Plus, go ahead, have that soda before math.
Latest News
Sleep time ‘sweet spot’ to slow cognitive decline identified?
Older adults who slept less than 4.5 hours or more than 6.5 hours a night reported significant cognitive decline over time.
Conference Coverage
Cannabis use: Messages remain mixed across diagnoses
Medscape Live and this news organization are owned by the same parent company. Dr. Martinez and Dr. Sarris reported no financial conflicts of...
From the Journals
Sleep time ‘sweet spot’ to slow cognitive decline identified?
The findings suggest that sleep may be a marker for Alzheimer’s disease progression.